Synopsis
Synopsis
0
CEP/COS
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (11beta)-17-(acetyloxy)-11-(4-(dimethylamino)phenyl)-19-norpregna-4,9-diene-3,20-dione
2. Ella Norpregnadiene
3. Esmya
1. 126784-99-4
2. Cdb-2914
3. Ella
4. Ellaone
5. Cdb 2914
6. Hrp 2000
7. Ulipristal Acetate [usan]
8. Va2914
9. (8s,11r,13s,14s,17r)-17-acetyl-11-(4-(dimethylamino)phenyl)-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl Acetate
10. (11beta)-17-(acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione
11. Yf7v70n02b
12. Chebi:71025
13. 17-acetoxy-11-(4-n,n-dimethylaminophenyl)pregna-4,9-diene-3,20-dione
14. Pgl-4001
15. Va-2914
16. Rti-3021-012
17. Ulipristal (acetate)
18. (11b)-17-(acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione
19. (11beta)-17-(acetyloxy)-11-(4-(dimethylamino)phenyl)-19-norpregna-4,9-diene-3,20-dione
20. (11beta,17alpha)-17-acetyl-11-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17-yl Acetate
21. 17beta-acetyl-11beta-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17alpha-yl Acetate
22. Unii-yf7v70n02b
23. Hrp-2000
24. Ulipristal Acet
25. Mfcd00899035
26. 4oar
27. Ulipristal-acetate
28. Ella Norpregnadiene
29. [(8s,11r,13s,14s,17r)-17-acetyl-11-[4-(dimethylamino)phenyl]-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] Acetate
30. Cbd 2914
31. Ella (tn)
32. Rti 3021-012
33. C17 Epi Ulipristal Acetate
34. Schembl544957
35. Chembl260538
36. Gtpl7460
37. Ulipristal Acetate [mi]
38. Ulipristal Acetate (jan/usan)
39. Ulipristal Acetate [jan]
40. Dtxsid30155294
41. Ta[a]phenanthren-17-yl] Acetate
42. Ulipristal Acetate [vandf]
43. Ulipristal Acetate [mart.]
44. Ulipristal Acetate [who-dd]
45. Zinc3920657
46. Bdbm50375424
47. Ulipristal Acetate, >=98% (hplc)
48. Akos026750526
49. Ccg-269500
50. Cs-1157
51. Ulipristal Acetate [orange Book]
52. Ncgc00378913-02
53. [(8s,11r,13s,14s,17r)-17-acetyl-11-(4-dimethylaminophenyl)-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] Acetate
54. As-73950
55. Bu161520
56. Hy-16508
57. U0102
58. C72119
59. D09687
60. Ab01566874_01
61. 784a994
62. Q975059
63. J-005436
64. Brd-k64381438-001-03-8
65. Z2216208644
66. 5-(hydroxymethyl)-alpha,alpha,alpha,alpha-tetramethyl-1,3-benzenediacetonitrile
67. (10s,11s,14r,15s,17r)-14-acetyl-17-[4-(dimethylamino)phenyl]-15-methyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1,6-dien-14-yl Acetate
68. (11.beta.)-17-(acetyloxy)-11-(4-(dimethylamino)phenyl)-19-norpregna-4,9-diene-3,20-dione
69. (11alpha,13alpha,17beta)-17-acetyl-11-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17-yl Acetate
70. (1r,3as,3bs,10r,11as)-1-acetyl-10-[4-(dimethylamino)phenyl]-11a-methyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,7h,8h,9h,10h,11h,11ah-cyclopenta[a]phenanthren-1-yl Acetate
71. (8s,11r,13s,14s,17r)-17-acetyl-11-(4-(dimethylamino)phenyl)-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-ylacetate
72. [(8s,11r,13s,14s,17r)-17-acetyl-11-[4-(dimethylamino)phenyl]-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopen
73. 17.alpha.-acetoxy-11.beta.-(4-dimethylaminophenyl)-19-norpregna-4,9-dien-3,20-dione
74. 19-norpregna-4,9-diene-3,20-dione, 17-(acetyloxy)-11-(4-(dimethylamino)phenyl)-, (11beta)-
75. C17 Isomer Ulipristal Acetate; (10s,11s,14s,15s,17r)-14-acetyl-17-[p-(dimethylamino)phenyl]-15-methyl-5-oxotetracyclo[8.7.0.02,7.011,15]heptadeca-1,6-dien-14-yl Acetate
76. Cbd 2914; Va 2914; (11b)-17-(acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione
Molecular Weight | 475.6 g/mol |
---|---|
Molecular Formula | C30H37NO4 |
XLogP3 | 3.5 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 5 |
Exact Mass | 475.27225866 g/mol |
Monoisotopic Mass | 475.27225866 g/mol |
Topological Polar Surface Area | 63.7 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 984 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Ulipristal acetate is indicated for one treatment course of pre-operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.
Ulipristal acetate is indicated for intermittent treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age who are not eligible for surgery.
Emergency contraception within 120 hours (five days) of unprotected sexual intercourse or contraceptive failure.
Contraception
Leiomyoma of uterus
Contraceptive Agents, Female
Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. (See all compounds classified as Contraceptive Agents, Female.)
Contraceptive Agents, Hormonal
Contraceptive agents that act on the ENDOCRINE SYSTEM. (See all compounds classified as Contraceptive Agents, Hormonal.)
G03XB02
G03AD02
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Complete
Rev. Date : 2014-06-24
Pay. Date : 2014-02-24
DMF Number : 27945
Submission : 2014-04-13
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21527
Submission : 2008-04-11
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25701
Submission : 2012-01-09
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26861
Submission : 2013-02-04
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12920
Submission : 1998-04-07
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2024-07-17
Pay. Date : 2024-05-28
DMF Number : 32954
Submission : 2018-07-27
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-09-23
Pay. Date : 2018-05-18
DMF Number : 32234
Submission : 2017-11-17
Status : Active
Type : II
Registration Number : 301MF10081
Registrant's Address : Parque Tecnologico-Parcela 105 Boecillo (Valladolid) Spain
Initial Date of Registration : 2019-10-25
Latest Date of Registration : 2019-10-25
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
About the Company : Symbiotec, a leading API manufacturing company based in Indore, Central India, specializes in Cortico-Steroids and Steroid-Hormone APIs. Since 1995, their focus on R&D, sustainable...
About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering g...
About the Company : Green Stone Swiss Co ., ltd.is a high-tech enterprise of pharmaceuticals and health ingredients, and provide customized products/OEM/ODM. We signed technical cooperation agreements...
About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...
About the Company : HANGZHOU THINK CHEMICAL CO., LTD. (THINKCHEM) is an integrative corporation of trade, research and contract manufacture. With about ten years of business experiences on the marketi...
About the Company : We are Maiden, a rapidly growing Indian pharma company committed to developing, manufacturing and marketing diverse portfolio of products. Our core strength lies in development, up...
About the Company : NAARI, meaning woman in Sanskrit, embodies the philosophy and objectives of our Organization. NAARI is a Swiss Pharmaceuticals company focused on female health with an emphasis on...
About the Company : Nanjing Bold Chemical Co., Ltd. is a high-tech enterprise dedicated to product development, production, sales and supply chain management in the field of pharmaceutical chemistry. ...
About the Company : NEWCHEM is an independent Italian manufacturer of Active Pharmaceutical Ingredients (APIs) - Steroids, Progestogens, Prostafglandins. NEWCHEM is active on the worldwide Pharmaceut...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Ella
Dosage Form : TAB
Dosage Strength : 30mg
Packaging : 1X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : Spain
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Regulatory Info :
Registration Country : Sweden
Brand Name : Esmya
Dosage Form : TABLETT
Dosage Strength : 5 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Esmya
Dosage Form : Ulipristal 5Mg 28 Combined Oral Use
Dosage Strength : 28 CPR 5 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Esmya
Dosage Form : Antic-calc Tablet
Dosage Strength : 5 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : RX
Registration Country : USA
Brand Name : ELLA
Dosage Form : TABLET;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2010-08-13
Application Number : 22474
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Canada
Brand Name : ELLA
Dosage Form : TABLET
Dosage Strength : 30MG
Packaging : 1
Approval Date :
Application Number : 2436329
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : India
Brand Name : Ulipristal Acetate
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging : 1x10
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : LOGILIA
Dosage Form : TABLET;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2017-02-13
Application Number : 207952
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Egypt
Brand Name : Norpregna
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Egypt
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Dosage Form : Tablet
Grade : Not Available
Application : Disintegrants & Superdisintegrants
Excipient Details : It is a superdisintegrant that provides an efficient disintegration at low level of use
Dosage Form : Tablet
Grade : Oral
Application : Granulation
Excipient Details : HiCellac is used in direct compression & dry granulation suitable for low dose formulations where API content uniformity is critical.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Lactose Monohydrate
Dosage Form : Tablet
Grade : Oral
Application : Granulation
Excipient Details : Hilose is used in oral pharmaceutical formulations as a super disintegrant for capsules and tablets formulations.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Croscarmellose Sodium
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
87
PharmaCompass offers a list of Ulipristal Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ulipristal Acetate manufacturer or Ulipristal Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ulipristal Acetate manufacturer or Ulipristal Acetate supplier.
PharmaCompass also assists you with knowing the Ulipristal Acetate API Price utilized in the formulation of products. Ulipristal Acetate API Price is not always fixed or binding as the Ulipristal Acetate Price is obtained through a variety of data sources. The Ulipristal Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A LOGILIA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LOGILIA, including repackagers and relabelers. The FDA regulates LOGILIA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LOGILIA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of LOGILIA manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A LOGILIA supplier is an individual or a company that provides LOGILIA active pharmaceutical ingredient (API) or LOGILIA finished formulations upon request. The LOGILIA suppliers may include LOGILIA API manufacturers, exporters, distributors and traders.
click here to find a list of LOGILIA suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A LOGILIA DMF (Drug Master File) is a document detailing the whole manufacturing process of LOGILIA active pharmaceutical ingredient (API) in detail. Different forms of LOGILIA DMFs exist exist since differing nations have different regulations, such as LOGILIA USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A LOGILIA DMF submitted to regulatory agencies in the US is known as a USDMF. LOGILIA USDMF includes data on LOGILIA's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The LOGILIA USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of LOGILIA suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The LOGILIA Drug Master File in Japan (LOGILIA JDMF) empowers LOGILIA API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the LOGILIA JDMF during the approval evaluation for pharmaceutical products. At the time of LOGILIA JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of LOGILIA suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a LOGILIA Drug Master File in Korea (LOGILIA KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of LOGILIA. The MFDS reviews the LOGILIA KDMF as part of the drug registration process and uses the information provided in the LOGILIA KDMF to evaluate the safety and efficacy of the drug.
After submitting a LOGILIA KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their LOGILIA API can apply through the Korea Drug Master File (KDMF).
click here to find a list of LOGILIA suppliers with KDMF on PharmaCompass.
A LOGILIA written confirmation (LOGILIA WC) is an official document issued by a regulatory agency to a LOGILIA manufacturer, verifying that the manufacturing facility of a LOGILIA active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting LOGILIA APIs or LOGILIA finished pharmaceutical products to another nation, regulatory agencies frequently require a LOGILIA WC (written confirmation) as part of the regulatory process.
click here to find a list of LOGILIA suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing LOGILIA as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for LOGILIA API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture LOGILIA as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain LOGILIA and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a LOGILIA NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of LOGILIA suppliers with NDC on PharmaCompass.
LOGILIA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LOGILIA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right LOGILIA GMP manufacturer or LOGILIA GMP API supplier for your needs.
A LOGILIA CoA (Certificate of Analysis) is a formal document that attests to LOGILIA's compliance with LOGILIA specifications and serves as a tool for batch-level quality control.
LOGILIA CoA mostly includes findings from lab analyses of a specific batch. For each LOGILIA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LOGILIA may be tested according to a variety of international standards, such as European Pharmacopoeia (LOGILIA EP), LOGILIA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LOGILIA USP).